Pacira Biosciences, Inc. (PCRX)
36.40
+0.09
(+0.25%)
USD |
NASDAQ |
Oct 14, 16:00
36.41
+0.01
(+0.03%)
After-Hours: 20:00
Pacira Biosciences Total Long Term Debt (Quarterly) : 401.82M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 401.82M |
| March 31, 2026 | 401.36M |
| December 31, 2025 | 408.36M |
| September 30, 2025 | 415.56M |
| June 30, 2025 | 621.78M |
| March 31, 2025 | 627.05M |
| December 31, 2024 | 629.97M |
| September 30, 2024 | 635.23M |
| June 30, 2024 | 639.45M |
| March 31, 2024 | 572.77M |
| December 31, 2023 | 577.24M |
| September 30, 2023 | 581.67M |
| June 30, 2023 | 611.73M |
| March 31, 2023 | 616.21M |
| December 31, 2022 | 754.27M |
| September 30, 2022 | 813.27M |
| June 30, 2022 | 823.23M |
| March 31, 2022 | 993.13M |
| December 31, 2021 | 1.121B |
| September 30, 2021 | 548.68M |
| June 30, 2021 | 543.62M |
| March 31, 2021 | 538.65M |
| December 31, 2020 | 533.70M |
| September 30, 2020 | 528.91M |
| June 30, 2020 | 388.07M |
| Date | Value |
|---|---|
| March 31, 2020 | 350.27M |
| December 31, 2019 | 346.98M |
| September 30, 2019 | 340.96M |
| June 30, 2019 | 337.23M |
| March 31, 2019 | 323.65M |
| December 31, 2018 | 290.59M |
| September 30, 2018 | 286.89M |
| June 30, 2018 | 283.26M |
| March 31, 2018 | 279.68M |
| December 31, 2017 | 276.17M |
| September 30, 2017 | 272.72M |
| June 30, 2017 | 269.33M |
| March 31, 2017 | 265.99M |
| December 31, 2016 | 108.74M |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.276M |
| September 30, 2014 | 0.602M |
| June 30, 2014 | 0.869M |
| March 31, 2014 | 1.065M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Viatris, Inc. | 13.51B |
| Johnson & Johnson | 0.00 |
| Liquidia Corp. | 182.90M |
| Organon & Co. | 8.553B |
| ANI Pharmaceuticals, Inc. | 610.49M |